Helen Roberts: Ledger

Stories naming Helen Roberts. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Chief Operating Officer	Kira Biotech	OneVentures portfolio (Mon 3 Aug 2020), OneVentures portfolio (Mon 28 Oct 2019)

Series A $20m

Immunology Company Kira Biotech launches with $20M Series A Funding

Brisbane immunology company Kira Biotech has launched with a $20 million Series A, OneVentures leading alongside IP Group and Queensland government support, to progress its lead antibody KB312 into early human studies.

OneVentures portfolio Mon 28 Oct 2019 Kira Biotech Centocor/Janssen Group of Eight Johnson & Johnson Sydney Local Health District The University of Sydney University of Queensland WE Buchan Biomedical Translation Fund IP Group Australia OneVentures Queensland Business Development Fund Dr Dan Baker Helen Roberts Michael Molinari Sarah Meibusch

Helen Roberts

Roles

Coverage

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

Immunology Company Kira Biotech launches with $20M Series A Funding